Market Share of Hydroxychloroquine Drugs Industry
Manufacturers offering generic versions dominate the global hydroxychloroquine drugs market. Companies are focusing on building generic chemical entities and innovative molecules to consolidate their foothold. Some of the prominent market participants are DR. REDDY'S LABORATORIES LTD, Laurus Labs Limited, Lupin, Mylan NV, Novartis International AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc., and Zydus Pharmaceuticals.
The introduction of generic versions and the strong clinical pipeline is anticipated to increase competition in the market. For instance, in April 2020, Zydus Cadila and Ipca Labs have backward integrated HCQ making capability with the aim to increase production capacity by 5-6 times to 70 MT per month thereby, expanding the range of treatment options for the millions of patients living with target diseases.
Hydroxychloroquine Drugs Market Leaders
-
Sanofi S.A
-
Sun Pharmaceutical Industries Ltd.
-
Mylan N.V
-
Teva Pharmaceuticals USA, Inc
-
Zydus Pharmaceuticals
*Disclaimer: Major Players sorted in no particular order
